Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (381-390 of 424) with videos related to

Pageof 43
Sort By:
Antiviral Research|March 1, 1990
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjectsJ W Mulder, F de Wolf, J Goudsmit, et al.
AIDS Research and Human Retroviruses|May 26, 2001
Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype CA Abebe, V V Lukashov, T F Rinke De Wit, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responsesD W Notermans, J J de Jong, J Goudsmit, et al.
Journal of Virology|November 23, 2000
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entryM Cayabyab, S Hinuma, M Farzan, et al.
Journal of Clinical Microbiology|May 15, 1999
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as targetM P de Baar, A M van der Schoot, J Goudsmit, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDSJ M Lange, D A Paul, H G Huisman, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Binding of HIV-1 to human follicular dendritic cellsP Joling, L J Bakker, D F van Wichen, et al.
Pageof 43

Showing results (381-390 of 424) with videos related to

Sort By:
Pageof 43
Antiviral Research|March 1, 1990
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjectsJ W Mulder, F de Wolf, J Goudsmit, et al.
AIDS Research and Human Retroviruses|May 26, 2001
Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype CA Abebe, V V Lukashov, T F Rinke De Wit, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responsesD W Notermans, J J de Jong, J Goudsmit, et al.
Journal of Virology|November 23, 2000
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entryM Cayabyab, S Hinuma, M Farzan, et al.
Journal of Clinical Microbiology|May 15, 1999
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as targetM P de Baar, A M van der Schoot, J Goudsmit, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDSJ M Lange, D A Paul, H G Huisman, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Binding of HIV-1 to human follicular dendritic cellsP Joling, L J Bakker, D F van Wichen, et al.
Pageof 43